Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
about
The endothelium abridges insulin resistance to premature agingAdherence to Mediterranean diet and risk of developing diabetes: prospective cohort studyBiomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritisVitamin D & endothelial functionVascular Effects of Dietary Advanced Glycation End ProductsThe HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesBlood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart studyA functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivityImproved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibilityCirculating cellular adhesion molecules and risk of diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).Circulating vascular cell adhesion molecule-1 is associated with cerebral blood flow dysregulation, mobility impairment, and falls in older adultsCocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension.Insulin and insulin-like growth factor-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells.The interactive role of type 2 diabetes mellitus and E-selectin S128R mutation on susceptibility to coronary heart disease.Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications.Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitusVariation in CHI3LI in relation to type 2 diabetes and related quantitative traits.Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study.The impact of vitamin D supplement intake on vascular endothelial function; a systematic review and meta-analysis of randomized controlled trials.Blood-based biomarkers of microvascular pathology in Alzheimer's disease.Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjectsGenetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.Association of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetesDepression, daily stressors and inflammatory responses to high-fat meals: when stress overrides healthier food choices.Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Vascular risk factors: imaging and neuropathologic correlates.Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: the Rancho Bernardo Study.Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes.Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009.The tsim tsoum approaches for prevention of cardiovascular diseaseAssociation of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China.Ambient Air Pollution and Type 2 Diabetes: A Systematic Review of Epidemiologic ResearchPancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus.ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey.Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia
P2860
Q24605364-E997EB10-306D-4E5C-9A3F-079C423D45EAQ24656559-44C61E62-A5C6-432A-8EC3-F9C80E030E0DQ24816784-AB2ED6BF-A8AC-40E5-ADE7-8C7B33EADBBBQ26824885-0548EC3A-DC40-4CD5-A267-32CE9A2452A2Q28081090-4EA67BBC-1E6D-43BE-9F76-90E51A1EB547Q28188518-59C7EC9B-E0C2-4C04-AF4B-3F89DE42A5F1Q28387157-E06DD76E-39D9-477D-BB03-3865FABCCE64Q28730293-84EF742D-EA0C-4128-951A-581BB4A2049CQ28731029-9D38C3D1-6E83-4A0B-A299-4B313A057308Q28756697-3E748A3E-8EBA-4BF1-B992-EEC9C430585CQ30277225-73F18216-5CCC-4E45-AA51-E0180740D436Q30377613-FDEE42E5-C539-4BEC-A981-3BCFA262728AQ30434226-37BA8369-1BEE-46A4-9FF7-03F6147E232DQ30435281-5A09FD6C-E3CC-4BCF-AA76-5367A509C5BEQ33288205-869D03B2-48C7-4B06-9F7A-1CE49D0DAB50Q33327392-62B00465-7AAB-4F0A-85A5-9C43EBF75914Q33357265-895C7F3F-4685-41A4-82C7-16E573E4E68EQ33392407-3CFE4EF7-7926-4845-B159-7A900693F001Q33440635-DC46B617-CF2F-4820-8664-0153F004E44FQ33556240-C2C62EF2-0B9F-4A7C-BECB-114A3D609E35Q33560555-CA0D4948-4C04-4A4E-80E8-C7CEBFED3DD3Q33601483-C4DB0A2F-A1C6-4D8F-8757-FB6F7191CFD5Q33625663-A171ABB8-A290-444A-B2B9-1FEBABE063A8Q33723943-3C03A964-A78A-4CDC-BEA0-5C8DA383ABE1Q33773702-40D17470-0E3D-4044-A48C-02F6AD0123C4Q33857620-DA0579AA-3B5C-4F30-92CB-B7097666D440Q33900800-DE252943-3A92-47AB-9964-1F143931DC47Q33901576-962EBDA0-9698-4CF7-A3B8-7FE68C15DBEEQ33905844-FD94586C-4182-4B6C-9ACD-8C40E74F555DQ33926678-AC43B695-79B2-4D11-83EF-20B20DBDEBA8Q33960856-299B3195-C93A-4AA8-9B2F-879092A2C285Q34016157-42869389-6D7B-4065-AF3C-A4188257EA2DQ34021697-A8B769B1-7972-4587-BA2F-1D1D95E3A7E9Q34046520-517A4B80-B151-45D9-B295-671FFAC2F43CQ34081067-7E0891C5-BD75-4E99-A5B7-30DA7FA493C2Q34094983-ACEA5308-4E8B-4351-A728-05CDCB4B7566Q34110586-6A2AA5F1-6C33-42F7-970D-D2A4D5DD4882Q34123927-39E1DACD-153D-41A9-B300-9954018D7A6EQ34126561-BFAD0400-EE1C-402E-BF91-A4F19D2B56E8Q34235400-72FC7719-C2AD-4A55-A4EC-B6A4FA9DB708
P2860
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@en
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@nl
type
label
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@en
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@nl
prefLabel
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@en
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@nl
P50
P921
P356
P1476
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
@en
P2093
JoAnn E Manson
P304
P356
10.1001/JAMA.291.16.1978
P407
P577
2004-04-01T00:00:00Z